Ipsen Group - Company & Market Research Reports

Home /
Companies /
Ipsen Group

Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases. The company offers drugs in urology – oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology, and cardiovascular areas. Its products include Decapeptyl, Hexvix, Somatuline, NutropinAq and Dysport. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 77
Central Nervous System Drugs 59
Endocrine and Metabolic Disorders Drugs 46
Drug Discovery 32
Infusions and Injectables 24
Musculoskeletal Disorders Drugs 23
Surgical Procedures 19
Pharmaceuticals 18
Biopharmaceuticals 15
Prostate Cancer Drugs 12
Clinical Trials 12
Drug Delivery 11
Liver Cancer Drugs 10
Women's Health 10
Dermatology 9
Pancreatic Cancer Drugs 9
Neurology 8
Lung Cancer Drugs 8
Biotechnology 7
Healthcare Services 7
Immune Disorders Drugs 7
Breast Cancer Drugs 6
Medical Devices 6
Gastrointestinal Drugs 6
Liver and Kidney Disorders Drugs 6
Thyroid Cancer Drugs 6
Sexual and Reproductive Health Drugs 6
Company Reports 5
Ovarian Cancer Drugs 5
Genomics 5
Diagnostics 5
Oncology 5
Urology and Nephrology 4
Brain Cancer Drugs 4
Bladder Cancer Drugs 4
Enzymes 4
Over the Counter (OTC) Drugs 4
Dermatological Drugs 4
Therapeutic Area 3
Drugs by Therapeutic Area 3
Cardiovascular Drugs 3
Colon Cancer Drugs 3
Managed Care 3
Kidney Cancer Drugs 3
Pediatrics 3
Gastroenterology 3
Optical Disorders Drugs 2
Lymphoma Drugs 2
In Vitro Diagnostics 2
Healthcare 2
Needles and Syringes 2
Surgical Devices 2
Biosimilars and Biosuperiors 2
Skin Cancer Drugs 2
Nanomedicine 2
Urological Disorders Drugs 2
Pharmaceutical Manufacturing 2
Pharmaceutical Intermediates 1
Allergy and Immunology 1
Infectious Diseases Drugs 1
Leukemia Drugs 1
Cervical Cancer Drugs 1
Point-of-Care Diagnostics 1
Infectious Disease Testing 1
Analgesics 1
Diabetes Devices 1
Transdermal and Transmucosal Drug Delivery 1
Biomaterials 1
Hematology 1
Hematological Drugs 1
Nuclear Medicine and Radiopharmacology 1
Other Healthcare Facilities 1
Laboratory Equipment 1
Anti-Obesity Drugs 1
Intensive Care and Emergency Medicine 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

418 Results (Page 11 of 21)
- Relevance
  Sort by

Europe Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
82 Pages
Europe

From

€1374EUR$1,500USD£1,170GBP

LAMEA Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
82 Pages
Africa, Middle East

From

€1374EUR$1,500USD£1,170GBP

North America Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
72 Pages
North America

From

€1374EUR$1,500USD£1,170GBP

Asia Pacific Muscle Relaxant Drugs Market Size, Share & Industry Trends Analysis Report By Drug Type, By Route of Administration (Oral and Injectable), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

 Report
May 2023
83 Pages
Asia Pacific

From

€1374EUR$1,500USD£1,170GBP

Muscle Spasticity - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1374EUR$1,500USD£1,170GBP

NEED HELP FINDING THE RIGHT PRODUCT? Becky will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Bromhidrosis Disease Treatment Market 2022-2026

 Report
June 2022
120 Pages
Global

From

€2290EUR$2,500USD£1,949GBP

Botulinum Toxin Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
117 Pages
Global

From

€4121EUR$4,500USD£3,509GBP

Botulinum Toxin Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4532EUR$4,949USD£3,859GBP

Tie-2 Modulators - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1374EUR$1,500USD£1,170GBP

Neuroendocrine Carcinoma Market Report and Forecast 2024-2032

 Report
February 2024
180 Pages
Global

From

€4551EUR$4,969USD£3,874GBP

Growth Hormone Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1145EUR$1,250USD£975GBP

Gallbladder Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1374EUR$1,500USD£1,170GBP

Cervical Dystonia Therapeutics Market 2021-2025

 Report
January 2022
120 Pages
Global

From

€2290EUR$2,500USD£1,949GBP

D1 Agonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1145EUR$1,250USD£975GBP

Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
507 Pages
Global

From

€2290EUR$2,500USD£1,949GBP

Atypical Teratoid Rhabdoid Tumours Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4532EUR$4,949USD£3,859GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2290EUR$2,500USD£1,949GBP

Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
746 Pages
Global

From

€2290EUR$2,500USD£1,949GBP

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1145EUR$1,250USD£975GBP

Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
August 2022
871 Pages
Global

From

€2290EUR$2,500USD£1,949GBP

418 Results (Page 11 of 21)
- 1
- 9
- 10
- 11
- 12
- 13

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.